Literature DB >> 29636880

Umbilical cord mesenchymal stem cell (UC-MSC) transplantations for cerebral palsy.

Huajiang Dong1,2, Gang Li1, Chongzhi Shang3,4, Huijuan Yin2, Yuechen Luo5, Huipeng Meng1, Xiaohong Li3,4, Yali Wang1,6, Ling Lin1, Mingliang Zhao3,4.   

Abstract

This study reports a case of a 4-year-old boy patient with abnormalities of muscle tone, movement and motor skills, as well as unstable gait leading to frequent falls. The results of the electroencephalogram (EEG) indicate moderately abnormal EEG, accompanied by irregular seizures. Based on these clinical characteristics, the patient was diagnosed with cerebral palsy (CP) in our hospital. In this study, the patient was treated with umbilical cord mesenchymal stem cell (UC-MSC) transplantation therapy. This patient received UC-MSC transplantation 3 times (5.3*107) in total. After three successive cell transplantations, the patient recovered well and showed obvious improvements in EEG and limb strength, motor function, and language expression. However, the improvement in intelligence quotient (IQ) was less obvious. These results indicate that UC-MSC transplantation is a promising treatment for cerebral palsy.

Entities:  

Keywords:  Cerebral palsy; mesenchymal stem cell; transplantation; umbilical cord

Year:  2018        PMID: 29636880      PMCID: PMC5883131     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  23 in total

1.  Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells.

Authors:  Seung-Hun Oh; Chunggab Choi; Da-Jeong Chang; Dong-Ah Shin; Nayeon Lee; Iksoo Jeon; Jong-Hyuk Sung; Hyunseung Lee; Kwan-Soo Hong; Jung Jae Ko; Jihwan Song
Journal:  Cytotherapy       Date:  2015-05-29       Impact factor: 5.414

Review 2.  Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.

Authors:  Silvia Berardis; Prenali Dwisthi Sattwika; Mustapha Najimi; Etienne Marc Sokal
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  The research progress of mesenchymal stem cells in the treatment of Traumatic brain injury.

Authors:  Gang Li; Yue Yang; Hua-Jiang Dong; Ling Lin
Journal:  Turk Neurosurg       Date:  2017-07-16       Impact factor: 1.003

4.  The potential value of Adipose Tissue-Derived((rAT)) Mesenchymal Stem Cells (MSCs).

Authors:  Huajiang Dong; Gang Li; Hong-Jun Ding; Yuechen Luo; Mingliang Zhao; Ling Lin
Journal:  Turk Neurosurg       Date:  2017-09-17       Impact factor: 1.003

5.  Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow.

Authors:  Dolores Baksh; Raphael Yao; Rocky S Tuan
Journal:  Stem Cells       Date:  2007-03-01       Impact factor: 6.277

6.  Intravenous mesenchymal stem cell therapy for traumatic brain injury.

Authors:  Matthew T Harting; Fernando Jimenez; Hasan Xue; Uwe M Fischer; James Baumgartner; Pramod K Dash; Charles S Cox
Journal:  J Neurosurg       Date:  2009-06       Impact factor: 5.115

7.  Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models.

Authors:  Lianhua Bai; Donald P Lennon; Arnold I Caplan; Anne DeChant; Jordan Hecker; Janet Kranso; Anita Zaremba; Robert H Miller
Journal:  Nat Neurosci       Date:  2012-06       Impact factor: 24.884

8.  Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury.

Authors:  Layla T Galindo; Thais R M Filippo; Patricia Semedo; Carolina B Ariza; Caroline M Moreira; Niels O S Camara; Marimelia A Porcionatto
Journal:  Neurol Res Int       Date:  2011-06-09

9.  Exosomes as potential alternatives to stem cell therapy for intervertebral disc degeneration: in-vitro study on exosomes in interaction of nucleus pulposus cells and bone marrow mesenchymal stem cells.

Authors:  Kang Lu; Hai-Yin Li; Kuang Yang; Jun-Long Wu; Xiao-Wei Cai; Yue Zhou; Chang-Qing Li
Journal:  Stem Cell Res Ther       Date:  2017-05-10       Impact factor: 6.832

10.  Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis.

Authors:  Motohiro Komaki; Yuri Numata; Chikako Morioka; Izumi Honda; Masayuki Tooi; Naoki Yokoyama; Hirohito Ayame; Kengo Iwasaki; Atsuko Taki; Noriko Oshima; Ikuo Morita
Journal:  Stem Cell Res Ther       Date:  2017-10-03       Impact factor: 6.832

View more
  5 in total

Review 1.  Progress in clinical trials of stem cell therapy for cerebral palsy.

Authors:  Zhong-Yue Lv; Ying Li; Jing Liu
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

2.  Wharton's Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study.

Authors:  Dariusz Boruczkowski; Izabela Zdolińska-Malinowska
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

3.  Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.

Authors:  Jiaowei Gu; Li Huang; Che Zhang; Yong Wang; Ruibo Zhang; Ziliang Tu; Hengdong Wang; Xihui Zhou; Zhousheng Xiao; Zegan Liu; Xiang Hu; Zunchen Ke; Dabin Wang; Li Liu
Journal:  Stem Cell Res Ther       Date:  2020-02-03       Impact factor: 6.832

4.  Human pluripotent stem cell-derived ectomesenchymal stromal cells promote more robust functional recovery than umbilical cord-derived mesenchymal stromal cells after hypoxic-ischaemic brain damage.

Authors:  Jiawei Huang; Kin Pong U; Fuyuan Yang; Zeyuan Ji; Jiacheng Lin; Zhihui Weng; Lai Ling Tsang; Tobias D Merson; Ye Chun Ruan; Chao Wan; Gang Li; Xiaohua Jiang
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 5.  Comparison of similar cells: Mesenchymal stromal cells and fibroblasts.

Authors:  Burcu Ugurlu; Erdal Karaoz
Journal:  Acta Histochem       Date:  2020-10-12       Impact factor: 2.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.